Emblica officinalis Extracts Induce Apoptosis in Human Osteoclasts
Author Information
Author(s): Penolazzi Letizia, Lampronti Ilaria, Borgatti Monica, Khan Mahmud Tareq Hassan, Zennaro Margherita, Piva Roberta, Gambari Roberto
Primary Institution: BioPharmaNet, ER-GenTech, Department of Biochemistry and Molecular Biology, Ferrara University, Ferrara, Italy
Hypothesis
Do extracts of Emblica officinalis fruits activate programmed cell death in human primary osteoclasts?
Conclusion
Emblica officinalis extracts can induce apoptosis in osteoclasts, suggesting their potential use in treating rheumatoid arthritis and osteoporosis.
Supporting Evidence
- Emblica officinalis extracts increased the expression levels of Fas, a key protein in the apoptosis pathway.
- Apoptosis levels in osteoclasts increased significantly with higher concentrations of the extracts.
- NF-kB activity was inhibited by Emblica officinalis extracts, affecting the expression of interleukin-6.
Takeaway
This study found that a plant called Emblica officinalis can help make certain bone cells called osteoclasts die, which might help with bone diseases.
Methodology
The study used human primary osteoclasts obtained from peripheral blood and assessed the effects of Emblica officinalis extracts on apoptosis and NF-kB activity.
Limitations
The study is based on in vitro results, and the effects in vivo need further investigation.
Participant Demographics
Human primary osteoclasts were derived from healthy normal volunteers.
Statistical Information
P-Value
<0.005
Statistical Significance
p<0.005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website